price
IP
NASDAQ · IPHA
Innate Pharma S.A.
Healthcare · Biotechnology
$1.62
Up+$0.14 (+9.46%)
Updated Oct 11, 2026, 1:59 AM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 159.21M
- P/E ratio
- -3.1
- Dividend yield
- 0.00%
- 52-week range
- $1.17 – $2.71
- Volume
- 46.88K
- Avg. volume
- 194.86K
Price performance · IPHA
IPHA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
IPHA closed at $1.62 after 20 trading sessions, down 12.43% for the selected period.
- Last close
- $1.62
- Period change
- -12.43%
- Period low
- $1.48
- Period high
- $2.01
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $1.49 | $1.68 | $1.49 | $1.62 | 46.88K |
| Oct 8, 2026 | $1.505 | $1.54 | $1.47 | $1.48 | 18.37K |
| Oct 7, 2026 | $1.54 | $1.55 | $1.5001 | $1.52 | 13.82K |
| Oct 6, 2026 | $1.58 | $1.65 | $1.53 | $1.59 | 133.73K |
| Oct 5, 2026 | $1.545 | $1.69 | $1.5325 | $1.58 | 107.79K |
| Oct 2, 2026 | $1.56 | $1.69 | $1.53 | $1.56 | 92.74K |
| Oct 1, 2026 | $1.595 | $1.67 | $1.58 | $1.59 | 64.05K |
| Sep 30, 2026 | $1.61 | $1.78 | $1.61 | $1.63 | 37.81K |
| Sep 29, 2026 | $1.63 | $1.6653 | $1.59 | $1.60 | 31.8K |
| Sep 28, 2026 | $1.71 | $1.79 | $1.66 | $1.70 | 42.27K |
| Sep 25, 2026 | $1.67 | $1.70 | $1.6101 | $1.70 | 31.02K |
| Sep 24, 2026 | $1.7232 | $1.73 | $1.69 | $1.70 | 17.69K |
| Sep 23, 2026 | $1.81 | $1.81 | $1.76 | $1.76 | 23.67K |
| Sep 22, 2026 | $1.84 | $1.84 | $1.77 | $1.80 | 55.82K |
| Sep 21, 2026 | $1.86 | $1.86 | $1.79 | $1.86 | 77.04K |
| Sep 18, 2026 | $1.92 | $1.94 | $1.8501 | $1.90 | 91.44K |
| Sep 17, 2026 | $1.99 | $1.99 | $1.82 | $1.91 | 193.77K |
| Sep 16, 2026 | $1.86 | $2.20 | $1.84 | $2.01 | 210.92K |
| Sep 15, 2026 | $1.85 | $1.92 | $1.84 | $1.86 | 47.79K |
| Sep 14, 2026 | $1.86 | $1.90 | $1.813 | $1.85 | 20.79K |
Latest IPHA news
The latest Smart Investors Daily articles mentioning IPHA.
Stock researchResearch & News · News
Company
Market Activity
Research & News
Loading stock research…